Related Experiment Video
Updated: Jun 19, 2026
09:29
Controlled Cortical Impact Model of Mouse Brain Injury with Therapeutic Transplantation of Human Induced Pluripotent Stem Cell-Derived Neural Cells
Published on: July 10, 2019
Stem Cell Therapy for Traumatic Brain Injury: Translational Mechanisms, Biomarkers, and Clinical Trials
William T Creel1, Sukhpreet Randhawa1, Richard E Hartman2
1Department of Psychology, Loma Linda University, Loma Linda, CA, 92354, USA.
Stem Cell Reviews and Reports
|June 18, 2026
Summary
Stem cell therapies offer promising neurorestoration for traumatic brain injury (TBI) by supporting neural repair. A framework is presented to guide clinical trials by aligning injury stage, biological targets, and outcomes for TBI treatment.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Clinical Trials
Background:
- Traumatic brain injury (TBI) causes significant long-term disability through primary damage and secondary injury cascades like neuroinflammation and oxidative stress.
- Current therapies targeting isolated secondary injury mechanisms show limited success, necessitating strategies for coordinated neural repair.
- Stem cell therapies show potential for neurorestoration in TBI, primarily through paracrine signaling and immunomodulation rather than direct cell replacement.
Purpose of the Study:
- To present a mechanism-aligned translational framework for stem cell-based therapies in TBI.
- To integrate knowledge of TBI repair mechanisms with clinical trial data.
- To inform the design of future clinical trials by optimizing treatment strategies based on injury stage, targets, and outcomes.
Main Methods:
- Review of current literature on TBI secondary injury mechanisms.
- Analysis of recent human clinical trials involving stem cell therapies for TBI.
- Development of a framework linking injury stage, biological targets, administration routes, and clinical outcomes.
Main Results:
- Stem cell therapies primarily exert neurorestorative effects via paracrine signaling, immunomodulation, and neurotrophic support.
- Clinical translation of stem cell therapies for TBI is hindered by heterogeneity in cell sources, delivery, timing, and outcome measures.
- Emerging data highlight safety, feasibility, and preliminary signals of efficacy across structural and functional endpoints.
Conclusions:
- A mechanism-aligned framework is crucial for advancing stem cell therapies in TBI.
- Optimizing treatment strategies requires careful consideration of injury stage, biological targets, delivery methods, and meaningful endpoints.
- Future clinical trial design should incorporate biomarker guidance to enhance treatment responsiveness and mechanistic understanding.
Related Concept Videos
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:28Traumatic Brain Injury l: Introduction
DefinitionTraumatic brain injury, or TBI, is a disturbance of normal brain function induced by an external mechanical force, such as a direct blow to the head or a penetrating injury. It can affect both brain structure and function, producing a wide range of clinical outcomes. TBI is a heterogeneous condition, meaning its effects may differ based on the type, location, and severity of the injury.Basis of ClassificationTBI is classified based on severity, injury mechanism, or pathophysiology. In...